Keywords: promising, preclinical, findings, morphosys, antibodies, germany, ag
Promising preclinical findings for MorphoSys' antibodies
Article | 27 October 2003
Germany's MorphoSys AG disclosed animal data at the Human Antibodies &Hybridoma Conference in Osaka, Japan, for its fully-human antibodies that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
